| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 18 May 2026 | 5 May 2026 |
| Zydus Wellness Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2026 inter alia to consider and approve audited financial results and recommend final dividend for the financial year ended on March 31 2026 Outcome of Board Meeting Appointment of Independent Director, record date, date of payment of Dividend and Thirty Second Annual General Meeting (As per BSE Announcement dated on: 18.05.2026) | ||
| Board Meeting | 3 Feb 2026 | 21 Jan 2026 |
| Zydus Wellness Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 inter alia to consider and approve unaudited financial results for the quarter and nine months ended on December 31 2025. Unaudited financial results for the quarter / nine months ended on December 31, 2025. (As per BSE announcement dated on : 03.02.2026) | ||
| Board Meeting | 5 Nov 2025 | 16 Oct 2025 |
| Zydus Wellness Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2025 inter alia to consider and approve Unaudited Financial Results for the quarter and half year ended September 30 2025 Unaudited financial results for the quarter and half year ended September 30, 2025 (As per BSE Announcement dated on: 05.11.2025) | ||
| Board Meeting | 30 Jul 2025 | 18 Jul 2025 |
| Zydus Wellness Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2025 inter alia to consider and approve unaudited financial results for the quarter ended on June 30 2025 Unaudited financial results for the quarter ended June 30, 2025 Unaudited financial results for the quarter ended June 30, 2025 (As Per BSE Announcement Dated on :30.07.2025) | ||
For FY25, it reported an adjusted operating profit of £21 million, with margins of 15.6%, ahead of Zydus Wellness’ own margins of about 14%.
With this, the UK company is now a wholly owned subsidiary of Alidac and becomes a step-down subsidiary of Zydus Wellness.
PAT margin came sharply at 1.4% against 0.1% in the same quarter last year.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
